4/9
02:11 pm
fenc
Those who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136% [Yahoo! Finance]
Low
Report
Those who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136% [Yahoo! Finance]
4/4
08:04 am
fenc
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its price target raised by analysts at HC Wainwright from $17.00 to $18.00. They now have a "buy" rating on the stock.
Low
Report
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its price target raised by analysts at HC Wainwright from $17.00 to $18.00. They now have a "buy" rating on the stock.
3/22
10:09 am
fenc
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/21
06:12 am
fenc
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update [Financial Post (Toronto, Ontario, Canada)]
High
Report
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update [Financial Post (Toronto, Ontario, Canada)]
3/21
06:09 am
fenc
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/21
06:00 am
fenc
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
High
Report
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
3/19
06:01 am
fenc
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
Low
Report
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
3/18
03:50 pm
fenc
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its price target raised by analysts at Craig Hallum from $17.00 to $18.00. They now have a "buy" rating on the stock.
Low
Report
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its price target raised by analysts at Craig Hallum from $17.00 to $18.00. They now have a "buy" rating on the stock.
3/18
12:09 pm
fenc
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $16.00 price target on the stock.
Low
Report
Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $16.00 price target on the stock.
3/18
03:00 am
fenc
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
High
Report
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
3/17
09:05 pm
fenc
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand [Yahoo! Finance]
High
Report
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand [Yahoo! Finance]
3/17
09:03 pm
fenc
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand [Financial Post (Toronto, Ontario, Canada)]
High
Report
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand [Financial Post (Toronto, Ontario, Canada)]
3/17
09:00 pm
fenc
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
High
Report
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
3/13
11:38 am
fenc
Analysts Are Optimistic We'll See A Profit From Fennec Pharmaceuticals Inc. (NASDAQ:FENC) [Yahoo! Finance]
Low
Report
Analysts Are Optimistic We'll See A Profit From Fennec Pharmaceuticals Inc. (NASDAQ:FENC) [Yahoo! Finance]
3/6
08:59 pm
fenc
Fennec Pharmaceuticals: Great Sales Progress - Not Yet Reflected In Stock Price [Seeking Alpha]
Low
Report
Fennec Pharmaceuticals: Great Sales Progress - Not Yet Reflected In Stock Price [Seeking Alpha]
2/29
07:23 am
fenc
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results [Yahoo! Finance]
Medium
Report
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results [Yahoo! Finance]
2/29
07:04 am
fenc
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
Low
Report
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
2/1
06:08 am
fenc
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin [Yahoo! Finance]
Neutral
Report
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin [Yahoo! Finance]
2/1
06:04 am
fenc
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin [Financial Post (Toronto, Ontario, Canada)]
Neutral
Report
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin [Financial Post (Toronto, Ontario, Canada)]
2/1
05:55 am
fenc
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
Neutral
Report
FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin